Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Novartis
Novartis
Kivu Bioscience Inc.
QuantumLeap Healthcare Collaborative
Mayo Clinic
Institut Curie
Hadassah Medical Organization
University of California, Irvine
Zhejiang Provincial People's Hospital
Innolake Biopharm
BioEclipse Therapeutics